DK0609255T3 - Fremgangsmåde og præparat til bestemmelse af den immunologiske aktivitet af bioaktive substanser - Google Patents

Fremgangsmåde og præparat til bestemmelse af den immunologiske aktivitet af bioaktive substanser

Info

Publication number
DK0609255T3
DK0609255T3 DK92920622.5T DK92920622T DK0609255T3 DK 0609255 T3 DK0609255 T3 DK 0609255T3 DK 92920622 T DK92920622 T DK 92920622T DK 0609255 T3 DK0609255 T3 DK 0609255T3
Authority
DK
Denmark
Prior art keywords
bioactive substances
immunological activity
tested
solution
determining
Prior art date
Application number
DK92920622.5T
Other languages
Danish (da)
English (en)
Inventor
Anna Inglot
Zofia Blach-Olszewska
Original Assignee
Torf Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torf Ets filed Critical Torf Ets
Application granted granted Critical
Publication of DK0609255T3 publication Critical patent/DK0609255T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK92920622.5T 1991-10-26 1992-09-28 Fremgangsmåde og præparat til bestemmelse af den immunologiske aktivitet af bioaktive substanser DK0609255T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91118269A EP0539610A1 (en) 1991-10-26 1991-10-26 Method and composition for determining the immunological activity of solutions containing active substances

Publications (1)

Publication Number Publication Date
DK0609255T3 true DK0609255T3 (da) 1997-12-22

Family

ID=8207282

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92920622.5T DK0609255T3 (da) 1991-10-26 1992-09-28 Fremgangsmåde og præparat til bestemmelse af den immunologiske aktivitet af bioaktive substanser

Country Status (22)

Country Link
US (1) US5543300A (OSRAM)
EP (2) EP0539610A1 (OSRAM)
JP (1) JPH07500905A (OSRAM)
AT (1) ATE153763T1 (OSRAM)
AU (1) AU678343B2 (OSRAM)
BG (1) BG61705B1 (OSRAM)
CA (1) CA2122131A1 (OSRAM)
CZ (1) CZ100494A3 (OSRAM)
DE (3) DE539610T1 (OSRAM)
DK (1) DK0609255T3 (OSRAM)
ES (1) ES2061424T3 (OSRAM)
FI (1) FI941920A0 (OSRAM)
GR (3) GR930300100T1 (OSRAM)
HU (1) HU216863B (OSRAM)
LV (1) LV12140B (OSRAM)
NO (1) NO941444L (OSRAM)
PL (1) PL170592B1 (OSRAM)
RO (1) RO114837B1 (OSRAM)
RU (1) RU2125727C1 (OSRAM)
SG (1) SG72665A1 (OSRAM)
SK (1) SK44094A3 (OSRAM)
WO (1) WO1993008470A1 (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615470A1 (de) * 1996-04-19 1997-10-23 Heinz Beinio Körperpflegemittel und Verfahren zu seiner Herstellung
WO2000016785A2 (en) * 1998-09-23 2000-03-30 Enerkom (Proprietary) Limited Humic acid and its use in the treatment of various conditions
RU2180120C1 (ru) * 2000-07-05 2002-02-27 Научно-исследовательский институт детских инфекций Способ выявления цитокинов
GB0101973D0 (en) * 2001-01-25 2001-03-14 Statens Seruminstitut Improved in vitro diagnostic method of detecting a cell-mediated immune response
RU2226275C2 (ru) * 2002-04-15 2004-03-27 Научно-исследовательский и учебно-методический центр биомедицинских технологий ВИЛАР Способ определения цитотоксического эффекта и ростстимулирующей активности веществ для доклинических испытаний
DE60304989T2 (de) * 2003-02-18 2007-03-29 Clinique La Prairie Research S.A. Zusammensetzungen enthaltend fötales Hämoglobin und bakterielles Endotoxin und fakultativ zusätzliche fötale Leberkomponenten
US7497947B2 (en) * 2004-04-14 2009-03-03 Embro Corporation Devices for water treatment
US7614340B2 (en) * 2007-02-09 2009-11-10 Honeywell International Inc. Composite piston housing for aircraft brakes
EP2753422A1 (en) 2011-09-07 2014-07-16 Embro Corporation Use of moss to reduce disinfection by-products in water treated with disinfectants
US9795809B2 (en) 2013-12-23 2017-10-24 Embro Corporation Use of moss to improve dental health
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH636448A5 (en) * 1977-05-06 1983-05-31 Horst Veith Process for the determination of the effect of substances on constituents of the blood for the detection of infectious and immunological processes and composition for carrying it out
NZ214400A (en) * 1985-12-02 1989-05-29 Univ Otago Detecting infection in ruminant including conducting assay of mononuclear cell function
DE3782958D1 (de) * 1986-02-19 1993-01-21 Imreg Inc Verfahren und mittel zum pruefen eines immunsystems.
ATE77488T1 (de) * 1986-03-06 1992-07-15 Commw Scient Ind Res Org In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.
US5096708A (en) * 1988-07-07 1992-03-17 Sven Gohla Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides
ATE131859T1 (de) * 1991-03-16 1996-01-15 Torf Ets Verfahren zur kontinuierlichen extraction von torf und apparat zur durchführung dieses verfahrens

Also Published As

Publication number Publication date
US5543300A (en) 1996-08-06
HU216863B (hu) 1999-09-28
ES2061424T3 (es) 1997-10-01
HK1002610A1 (en) 1998-09-04
CZ100494A3 (en) 1994-11-16
SK44094A3 (en) 1995-03-08
EP0609255A1 (en) 1994-08-10
LV12140B (lv) 1998-12-20
DE69220078D1 (de) 1997-07-03
PL170592B1 (en) 1997-01-31
DE539610T1 (de) 1993-12-16
AU2650992A (en) 1993-05-21
LV12140A (lv) 1998-09-20
GR940300077T1 (en) 1994-11-30
JPH07500905A (ja) 1995-01-26
DE609255T1 (de) 1995-06-14
AU678343B2 (en) 1997-05-29
GR930300100T1 (OSRAM) 1993-10-29
RO114837B1 (ro) 1999-07-30
ATE153763T1 (de) 1997-06-15
BG61705B1 (bg) 1998-03-31
HUT69990A (en) 1995-09-28
RU94022481A (ru) 1996-09-27
BG98720A (bg) 1995-07-28
HU9401185D0 (en) 1994-07-28
ES2061424T1 (es) 1994-12-16
CA2122131A1 (en) 1993-04-29
WO1993008470A1 (en) 1993-04-29
NO941444L (no) 1994-06-16
SG72665A1 (en) 2000-05-23
RU2125727C1 (ru) 1999-01-27
FI941920A7 (fi) 1994-04-25
DE69220078T2 (de) 1997-12-04
GR3024457T3 (en) 1997-11-28
EP0539610A1 (en) 1993-05-05
EP0609255B1 (en) 1997-05-28
FI941920L (fi) 1994-04-25
NO941444D0 (no) 1994-04-21
FI941920A0 (fi) 1994-04-25

Similar Documents

Publication Publication Date Title
DE122007000080I2 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen.
DK552684D0 (da) Desulfatohirudiner samt deres fremstilling og anvendelse
DK0609255T3 (da) Fremgangsmåde og præparat til bestemmelse af den immunologiske aktivitet af bioaktive substanser
DK235687D0 (da) Tilberedninger til syntese af prostaglandiner og hydroxyfedtsyrer i biologiske systemer og anvendelse deraf
DK165199C (da) Aktivatorpraeparat, fremgangsmaade til kvantitativ bestemmelse af protein c under anvendelse af praeparatet, antithrombotisk laegemiddel indeholdende praeparatet og fremgangsmaade til udvinding af aktiveret protein c under anvendelse af praeparatet
ATE113208T1 (de) Verwendung des wirkstoffs azelastin zur bekämpfung von psoriasis-erkrankungen.
ATE121100T1 (de) Ein neues thrombomodulin ähnliches glykoprotein erhältlich aus harn.
DK418986D0 (da) Pyrrolobenzimidazoler, pyrrolobenzoxazoler og pyrrolobenzthiazoler, fremgangsmaader til fremstilling heraf og laegemidler med indhold heraf
ATE27157T1 (de) Cycloalkylderivate von benzisoselenazolonen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
NO173336C (no) Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein
ATE196088T1 (de) Verfahren zur gewinnnung von zellkulturen mit erhöhtem gehalt an körpereigenen zytokinen
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
US3876774A (en) Method of using a simple protein derived from liver
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
ATE135702T1 (de) Aryl- oder heteroaryl-1-alkyl-pyrrol-2- carbonsäure-derivate, zur behandlung von durch interleukin-1 hervorgerufenen erkrankungen
DK183788A (da) Fremgangsmaade til foroegelse af levedygtigheden af frysetoerrede, maelkesyreproducerende bakteriekulturkoncentrater
DK299981A (da) Fremgangsmaade til fremstilling af 1-s-alkyl-2-0-acyl-3-phosphocolin-1-mercapto-2.3-propandioler
DK320081A (da) Fremgangsmaade til fremstilling af thiazolyl-2-oxamidsyrederivater
ATE59038T1 (de) Taurinderivat, seine herstellung und es enthaltende pharmazeutische zusammensetzungen.
JPS5722688A (en) Concentration of liquid containing nutrient component
DK440088A (da) Fremgangsmaade til fremstilling af n6-benzyloxycarbonyl-2,6-diaminopimelamsyre
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus
ATE13633T1 (de) Verfahren zur herstellung von hochgereinigtem antihaemophiliefaktor.
DK595885A (da) Fremgangsmaade og cellelinie til kontinuerlig dannelse af retrovirus(htlv-iii) beslaegtet med aids